Share on StockTwits

GTx (NASDAQ:GTXI) CEO Marc Steven Hanover acquired 20,000 shares of the stock on the open market in a transaction dated Thursday, August 21st. The shares were purchased at an average price of $1.00 per share, for a total transaction of $20,000.00. Following the completion of the transaction, the chief executive officer now directly owns 198,138 shares of the company’s stock, valued at approximately $198,138. The transaction was disclosed in a document filed with the SEC, which is available at this link.

GTx (NASDAQ:GTXI) traded up 2.05% during mid-day trading on Friday, hitting $0.99. 40,700 shares of the company’s stock traded hands. GTx has a 1-year low of $0.81 and a 1-year high of $2.36. The stock’s 50-day moving average is $1.19 and its 200-day moving average is $1.44. The company’s market cap is $75.3 million.

GTx (NASDAQ:GTXI) last announced its earnings results on Tuesday, August 5th. The company reported ($0.15) EPS for the quarter, missing the Thomson Reuters consensus estimate of ($0.12) by $0.03. During the same quarter in the prior year, the company posted ($0.20) earnings per share. On average, analysts predict that GTx will post $-0.48 earnings per share for the current fiscal year.

GTx, Inc is a biopharmaceutical company. The Company is developing selective androgen receptor modulators (NASDAQ:GTXI) , a drugs with the potential to prevents and treat muscle wasting in patients with cancer and other musculoskeletal wasting or muscle loss conditions, including chronic sarcopenia (age related muscle loss).

Receive News & Ratings for GTx Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GTx Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.